Tarsus is a biopharmaceutical company that develops therapies for demodex blepharitis and eye care.
Business Model:
Revenue: $16.2M
Employees: 11-50
Address: 15440 Laguna Canyon Road
City: Irvine
State: CA
Zip: 92618
Country: US
Tarsus is a biopharmaceutical company that develops therapies for demodex blepharitis and eye care.
Contact Phone:
+19494099820
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
10/15/2020
IPO Valuation:
$308M
Ticker Symbol:
TARS
IPO Price:
$16/share
Amount Raised:
$88M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 3/2018 | Series A | - | 5/2022 | Post-IPO Equity | $75.6M | 1/2020 | Series B | 6 | $60M |
Aperture Venture Partners Flying L Partners Frazier Healthcare Partners Horowitz Group Visionary Venture Fund Vivo Capital Aperture Venture Partners Flying L Partners Frazier Healthcare Partners Horowitz Group Visionary Venture Fund Vivo Capital |
10/2020 | IPO | $88M |
|
3/2018 | Series A | - |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|